Costco Q1 net sales up 7.5% to $60.99 billion - Breaking The News
Download our appPlay StoreApp Store

Costco Q1 net sales up 7.5% to $60.99 billion

EPA-EFE/ALLISON DINNER

Costco Wholesale Corp. unveiled on Thursday that its net sales in the first quarter of its fiscal 2025 stood at $60.99 billion, advancing by 7.5% compared to the same quarter from the previous year.

The warehouse store company's total revenue was $62.1 billion during the first trimester, gaining 7.5% year over year, and surpassing analysts' expectations. Diluted earnings per share (EPS) stood at $4.04, increasing by 12.8% compared to the same period of its fiscal 2024. Net income increased by 13.1% on an annual basis to clock in at $1.8 billion.

The company's stocks went up by 0.80% in the after-hours trading after the report was published.

Related Stocks
Costco Wholesale
Related News
Spotify monthly active users up 10% to 678M in Q1
Spotify Technology S.A. said on Wednesday that the number of its total monthly active users (MAU) in the first quarter of 2025 jumped 10% to 678 million users.More to come...
UPS' revenue falls 0.7% in Q1 to $21.5B
The United Parcel Service Inc. (UPS) announced on Tuesday that its revenue in the first quarter of its fiscal 2025 fell 0.7% annually to reach billion, slightly outperforming analysts' expectations. More to come...
BP's Q1 profit plunges 69% to $687 million
BP plc reported Tuesday that profit for the first quarter of fiscal 2025 fell 69% to $687 million from $2.263 billion a year earlier. Compared to fourth quarter 2024, lower operating cash flow, a weak gas marketing and trading result, and lower refining margins impacted results.With an operating cash flow of $2.8 billion, the company recorded an adjusted EBITDA of $8.7 billion, which is a 15.6% drop from the $10.3 billion recorded the previous year. Meanwhile, the...
AstraZeneca's Q1 revenue up 7% to $13.6 billion
AstraZeneca PLC announced on Tuesday that its revenue in the first quarter of the fiscal year 2025 saw an annual actual rise of 7%, 10% at constant exchange rate (CER), to hit $13.6 billion.The pharmaceutical company's product sales went up by 6%, 9% at CER year-on-year to reach $12.9 billion, while its core operating profit grew by 12%. Its reported earnings per share (EPS) jumped by 35%, 32% at CER, to $1.88. Furthermore, AstraZeneca predicted its...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.